A clinical trial of the shot in eight volunteers suggests that it is safe and that it generates antibodies that neutralize SARS-CoV-2, but further testing is needed, scientists say.

While the finding doesn’t prove people become immune to the virus after infection, it is good news for vaccine development.

Data from a crowdsourcing smartphone app is helping to track the spread of the disease in real time and reveals the symptom as the number one indicator of infection.

The FDA cracks down on test makers as independent evaluations of their products’ performance show a need for improvement.

Studies are underway to test whether giving a shot of BCG vaccine could protect doctors and nurses against COVID-19.

Look closer, with the largest portfolio of verified assays for Luminex® instruments. Entirely configurable to run the analytes of your choice.

Drugs targeting patients’ immune systems, rather than the virus itself, could be key to recovery from severe cases of the disease, some researchers suggest.

If governments were to use SARS-CoV-2 antibody tests to manage who can re-enter the workplace, society must accept a sacrifice of privacy.

Studies from serum samples could transform our understanding of the spread of COVID-19, but what antibodies alone say about immunity is not yet clear.

By studying influenza in mice and cells, researchers identify a glucose metabolism pathway critical to the dysregulated immune response that kills many infectious disease patients, including those with COVID-19.